Welcome to Cohesion Biosciences
Home> Products > Primary Antibody
CPA2344
  • Western blot analysis of DOK2 (Phospho-Y299) expression in K562 (A), H9C2 (B), HEK293T-EGF-30min (C), HEK293T-EGF-15min (D), HEK293T (E) whole cell lysates. (Predicted band size: 45 kD; Observed band size: 56 kD)
  • Immunohistochemical analysis of DOK2 (Phospho-Y299) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
  • Immunofluorescent analysis of DOK2 (Phospho-Y299) staining in HepG2 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a hidified chamber. Cells were washed with PBST and incubated with a AF594-conjugated secondary antibody (red) in PBS at room temperature in the dark.
Product Name:Anti-DOK2 (Phospho-Y299) Antibody
Cat No:CPA2344
Source:Rabbit
Reactivity:H, R
Applications:WB, IH, IF/IC
*Application Key:
H - Human, M - Mouse, R - Rat, B - Bovine, C - Chicken, D - Dog, G - Goat, Mk - Monkey, P - Pig, Rb - Rabbit, S - Sheep, Z - Zebrafish
*Species Reactivity Key:
E- ELISA, WB - Western blot, IH - Immunohistochemistry, IF - Immunofluorescence, FC - Flow cytometry, IC - Immunocytochemistry, IP - Immunoprecipitation, ChIP - Chromatin Immunoprecipitation, EMSA - Electrophoretic Mobility Shift Assay, BL - Blocking, SE - Sandwich ELISA, CBE - Cell-based ELISA, RNAi - RNA interference
Size
Price(USD)
200 μl
420
100 μl
260
30 μl
130
50 μl
170
Add to cart Ship in 3 days My orders
Description:Rabbit polyclonal antibody to DOK2 (Phospho-Y299)
Immunogen:KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding Y299 of human DOK2 protein. The exact sequence is proprietary.
Purification:The antibody was purified by immunogen affinity chromatography.
Clonality:Polyclonal
Form:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Dilution:WB (1/500 - 1/1000), IH (1/50 - 1/100), IF/IC (1/50 - 1/200)
Gene Symbol:DOK2
Alternative Names:Docking protein 2; Downstream of tyrosine kinase 2; p56(dok-2)
Entrez Gene (Human): 9046;
SwissProt (Human): O60496;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
  • Western blot analysis of DOK2 (Phospho-Y299) expression in K562 (A), H9C2 (B), HEK293T-EGF-30min (C), HEK293T-EGF-15min (D), HEK293T (E) whole cell lysates. (Predicted band size: 45 kD; Observed band size: 56 kD)
  • Immunohistochemical analysis of DOK2 (Phospho-Y299) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
  • Immunofluorescent analysis of DOK2 (Phospho-Y299) staining in HepG2 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a hidified chamber. Cells were washed with PBST and incubated with a AF594-conjugated secondary antibody (red) in PBS at room temperature in the dark.
Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity
Journal Arthritis Res Ther
IF 4.9
Application WB
Reactivity
PMID 22621248
COHESION BIOSCIENCES LIMITED
Copyright © 2022 Cohesion Biosciences. All Rights Reserved